We’re glad to see you’re enjoying ReachMD…but how about a more personalized experience?
ABC-ICH: Does Care Bundling Improve Outcomes for Patients with Intracranial Hemorrhage?
W. Brian Gibler, MD, FACEP, FACC, FAHA
Adrian R. Parry-Jones, FRCP, PhD
Stuart Connolly, MD, FRCPC
The Frontier of Stroke Diagnosis (RapidAI): How Can Artificial Intelligence Improve Acute Care for Ischemic and Hemorrhagic Stroke?
Greg Albers, MD
Rhonda Cadena, MD, FNCS, FCCM
Implementation of the 2022 AHA/ASA Guideline for the Management of Patients with Spontaneous Intracerebral Hemorrhage—Are You Doing Enough?
Emerging Data in the Management of Intracranial Hemorrhage in the Anticoagulated Patient
Optimizing ICH Care By Leveraging AC Reversal, AI & Care Bundling
Natalie Kreitzer, MD, MS
Providing Optimal Care for the Anticoagulated Patient with Intracranial Hemorrhage in the Acute Care Setting: Does the Patient Need Reversal, Repletion, or Surgery?
Repletion Management for Vitamin K Antagonist Anticoagulation
David Seiffge, MD
Specific Reversal Therapy for Factor Xa and Factor IIa Inhibitor-Associated ICH Life-Threatening Bleeding
Reversal of Factor Xa Inhibitor ICH: ANNEXA-4, ANNEXA-I and Real-World Evidence
Case Presentation: Management of ICH in the Anticoagulated Patient Using Specific Reversal Therapy: Importance of Timing
Audience Q&A
Repletion or Reversal? Optimizing Specific Therapy for Direct Oral Anticoagulant (DOAC)-Related Life-Threatening Bleeding Using Real-World Experience
Real World Data and the Management of Intracranial Hemorrhages (ICH) in Anticoagulated Patients
Case Presentation: Management of a Patient With Factor Xa-Associated ICH Using Specific Reversal Therapy
Development of a Care Pathway Using Specific Reversal Agents for Anticoagulated Patients With ICH
Press cancel to remain on ReachMD. Press the link below or the continue button to keep going.
Stay current with the best on medical education